Computational tool improves recombinant virus design efficiency and yield. This innovative in-house development is a key component of Transgene’s INTV1 platform. Poster to be presented at ESMO-AI 2025 Strasbourg, France, November 6, 2025, 8:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announced it will present a poster on its proprietary VacDesignR® computational tool at the upcoming ESMO AI & Digi ...